{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:00:59Z","timestamp":1760061659248},"reference-count":27,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3960\/jslrt.53.221","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T22:47:47Z","timestamp":1387925267000},"page":"221-226","source":"Crossref","is-referenced-by-count":13,"title":["Secondary Neurolymphomatosis Detected by Whole-Body Diffusion-Weighted Magnetic Resonance Imaging :A Case Report"],"prefix":"10.3960","volume":"53","author":[{"given":"Hiroaki","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Sakaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Kawajiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Nakaseko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, <I>et al<\/I>.: Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 115:5005-5011, 2010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH: Neurolymphomatosis. Neuro Oncol 5:104-115, 2003","DOI":"10.1215\/15228517-5-2-104"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Nishizawa M, Yamashita K, Nakamoto Y, Kotani S, Kondo T, <I>et al<\/I>.: Neurolymphomatosis as a manifestation of relapsed primary cardiac lymphoma. Int J Hematol 92:679-680, 2010","DOI":"10.1007\/s12185-010-0716-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Trojan A, Jermann M, Taverna C, Hany TF: Fusion PET-CT imaging of neurolymphomatosis. Ann Oncol 13:802-805, 2002","DOI":"10.1093\/annonc\/mdf057"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Bokstein F, Goor O, Shihman B, Rochkind S, Even-Sapir E, <I>et al<\/I>.: Assessment of neurolymphomatosis by brachial plexus biopsy and PET\/CT. Report of a case. J Neurooncol 72:163-167, 2005","DOI":"10.1007\/s11060-004-3389-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Suga K, Yasuhiko K, Matsunaga N, Yujiri T, Nakazora T, <I>et al<\/I>.: F-18 FDG PET\/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy. Clin Nucl Med 36:73-76, 2011","DOI":"10.1097\/RLU.0b013e3181f4a03f"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Matsue K, Hayama BY, Iwama KI, Koyama T, Fujiwara H, <I>et al<\/I>.: High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer 117:4512-4521, 2011","DOI":"10.1002\/cncr.26090"},{"key":"8","unstructured":"8 Stecco A, Romano G, Negru M, Volpe D, Saponaro A, <I>et al<\/I>.: Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol Med 114:1-17, 2009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Koh DM, Collins DJ: Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622-1635, 2007","DOI":"10.2214\/AJR.06.1403"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Yoshida S, Masuda H, Ishii C, Tanaka H, Fujii Y, <I>et al<\/I>.: Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR Am J Roentgenol 196:110-116, 2011","DOI":"10.2214\/AJR.10.4632"},{"key":"11","unstructured":"11 Kwee TC, van Ufford HM, Beek FJ, Takahara T, Uiterwaal CS, <I>et al<\/I>.: Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 44:683-690, 2009"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Lin C, Itti E, Luciani A, Haioun C, Meignan M, <I>et al<\/I>.: Whole-body diffusion-weighted imaging in lymphoma. Cancer Imaging 10 Spec no A:S172-178, 2010","DOI":"10.1102\/1470-7330.2010.9029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Lin C, Luciani A, Itti E, El-Gnaoui T, Vignaud A, <I>et al<\/I>.: Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 20:2027-2038, 2010","DOI":"10.1007\/s00330-010-1758-y"},{"key":"14","unstructured":"14 Lin C, Itti E, Luciani A, Zegai B, Lin SJ, <I>et al<\/I>.: Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol 46:341-349, 2011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kwee TC, Kwee RM, Nievelstein RA: Imaging in staging of malignant lymphoma: a systematic review. Blood 111:504-516, 2008","DOI":"10.1182\/blood-2007-07-101899"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kwee TC, Fijnheer R, Ludwig I, Quarles van Ufford HM, Uiterwaal CS, <I>et al<\/I>.: Whole-body magnetic resonance imaging, including diffusion-weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma. Br J Haematol 149:628-630, 2010","DOI":"10.1111\/j.1365-2141.2010.08093.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 St&eacute;phane V, Samuel B, Vincent D, Joelle G, Remy P, <I>et al<\/I>.: Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas. Eur J Radiol 82:2011-2017, 2013","DOI":"10.1016\/j.ejrad.2013.05.042"},{"key":"18","unstructured":"18 Gu J, Chan T, Zhang J, Leung AY, Kwong YL, <I>et al<\/I>.: Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 197:W384-391, 2011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Abdulqadhr G, Molin D, Astr&ouml;m G, Suurk&uuml;la M, Johansson L, <I>et al<\/I>.: Whole-body diffusion-weighted imaging compared with FDG-PET\/CT in staging of lymphoma patients. Acta Radiol 52:173-180, 2011","DOI":"10.1258\/ar.2010.100246"},{"key":"20","unstructured":"20 van Ufford HM, Kwee TC, Beek FJ, van Leeuwen MS, Takahara T, <I>et al<\/I>.: Newly diagnosed lymphoma: initial results with whole-body T 1-weighted, STIR, and diffusion-weighted MRI compared with 18 F-FDG PET\/CT. AJR Am J Roentgenol 196:662-669, 2011"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, <I>et al<\/I>.: Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497-505, 1988","DOI":"10.1148\/radiology.168.2.3393671"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Manon-Espaillat R, Lanska DJ, Ruff RL, Masaryk T: Visualization of isolated trigeminal nerve invasion by lymphoma using gadolinium-enhanced magnetic resonance imaging. Neuroradiology 32:531-532, 1990","DOI":"10.1007\/BF02426474"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Swarnkar A, Fukui MB, Fink DJ, Rao GR: MR imaging of brachial plexopathy in neurolymphomatosis. AJR Am J Roentgenol 169:1189-1190, 1997","DOI":"10.2214\/ajr.169.4.9308489"},{"key":"24","unstructured":"24 Takahara T, Hendrikse J, Yamashita T, Mali WP, Kwee TC, <I>et al<\/I>.: Diffusion-weighted MR neurography of the brachial plexus: feasibility study. Radiology 249:653-660, 2008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Liang R, Chiu E, Loke SL: Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors. Hematol Oncol 8:141-145, 1990","DOI":"10.1002\/hon.2900080305"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Arkenau HT, Chong G, Cunningham D, Watkins D, Agarwal R, <I>et al<\/I>.: The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Ann Oncol 18:541-545, 2007","DOI":"10.1093\/annonc\/mdl434"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Glantz MJ, Cole BF, Recht L, Akerley W, Mills P, <I>et al<\/I>.: High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 16:1561-1567, 998","DOI":"10.1200\/JCO.1998.16.4.1561"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:33Z","timestamp":1621539993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/53\/3\/53_221\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.53.221","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}